Why Women’s Healthcare Feels So Fragmented
HEALTH SYSTEM — The gap between your doctors is not a flaw. It’s the design.
A friend was sitting in an oncologist’s office when she mentioned, almost in passing that she’d been on the pill as a teenager. Her doctor had a theory that her early hormonal contraceptive use may have contributed to the breast cancer she was now fighting.
“Why would my gynecologist have put me on it,” she asked, “if that was the risk?”
The oncologist’s answer: “Oncologists and gynecologists are not in the same line of business.”
That is not an apology. That is a description of how medicine is structured—built around specialties, organized by what each specialty is trained to treat. Your gynecologist manages your reproductive health. An oncologist treats cancer. Both are doing their jobs. Neither job formally includes tracking what the other knows, what the other prescribed, or what that prescription may have set in motion. The gap between them is not a flaw. It is the design.
Specialization is how medicine makes progress. No one expects an oncologist to also be a gynecologist, or a cardiologist to also be a neurologist. The problem is not that doctors specialize. The problem is that the system was never designed—and is not financially incentivized—to coordinate between them.
Every physician visit generates CPT codes (Current Procedural Terminology) that documents what was done and tiggers reimbursement. Coordination codes exist, but the financial incentive to treat within a specialty dwarfs the incentive to coordinate across them. In theory, your primary care physician bridges that gap—holding the longitudinal record, integrating the picture. In practice, a 15-minute visit and fragmented records mean that layer rarely holds.
The oral contraceptive story is the clearest illustration of what that gap costs.
Research has documented a real connection between hormonal contraceptive use and elevated breast cancer risk. A 2017 study in the New England Journal of Medicine, following 1.8 million women over more than a decade, found meaningfully higher relative risk among users—rising with duration of use. Whether that research explains any individual case is impossible to say. But the more important question is: is it anyone’s job to make sure that research travels from the oncology literature to the gynecologist’s prescription pad—or the patient taking it?
Structurally, no. Oncologists don’t routinely review contraceptive history. Gynecologists don’t routinely counsel on long-term cancer risk. Patients don’t think to mention a prescription from decades ago. No single point of failure—which is exactly why it persists.
My friend’s oncologist was not being cruel. He was describing medicine as it exists. The system finds what it’s trained to look for, in the specialty it’s trained to look in. What lives in the gap—the longitudinal picture, the cross-specialty connection, the question you didn’t know to ask—is no one’s professional responsibility to surface.
Until you know that, you cannot protect yourself from it.
